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ABSTRACT
Objective: To identify the prevalence of osteoporosis in postmenopausal women and its association with risk factors. Methods: 
Cross-sectional study with 115 older postmenopausal women who participated in the extension project of the Federal District 
University Center lasting one year, starting in 2017. Bone mineral density was measured using Dual-energy X-ray absorptiometry 
technique on lumbar spine (L1-L4) and femoral neck. Risk factors for low density were evaluated through interviews. Statistical 
analysis was performed using the Chi-squared test (p<0.05). Results: The mean age was 67.8 ± 8.4 years and mean time since 
menopause was 16.7 ± 6.2 years. Mean bone mineral density was -0.96 ± 1.42 in the femoral neck and -1.25 ± 1.75 in the lumbar 
spine (L1-L4). The prevalence of low density was 66.9% for the lumbar spine and 52.1% for the femoral neck. We found a significant 
difference in age (50.5% between 51 and 55 years and low density), physical inactivity (82.9%), personal history of fracture in 
the last 5 years (31.2% with low density) and body mass index - overweight among women with normal bone mineral density 
(44.7%) when compared with those with low density (p<0.001). Conclusion: Postmenopausal women had a high prevalence of 
low bone mineral density and associated risk factors. 
Descriptors: Bone Density; Aging; Health Promotion.
RESUMO
Objetivo: Identificar a prevalência de osteoporose em mulheres na pós-menopausa e sua associação com fatores de risco. 
Métodos: Estudo transversal realizado com 115 idosas na pós-menopausa que participavam do projeto de extensão do Centro 
Universitário do Distrito Federal, com duração de um ano, com início em 2017. Mensurou-se a densidade mineral óssea pelo 
Dual-energy X-ray absorptiometry em coluna lombar (lombar 1 a lombar 4) e colo do fêmur. Por meio de  entrevista, avaliaram-se 
fatores de risco para baixa densidade. Na análise estatística, utilizou-se o teste qui-quadrado de Pearson(p<0,05). Resultados: 
A média de idade encontrada é de 67,8 ± 8,4 anos e o tempo de menopausa de 16,7 ± 6,2 anos. A média de densidade mineral 
óssea é de -0,96 ± 1,42 no colo do fêmur e de -1,25 ± 1,75 na coluna lombar (L1-L4). A prevalência de baixa densidade é de 
66,9% para coluna lombar e de 52,1% para colo de fêmur. Encontrou-se diferença significativa na idade (50,5% tinham entre 
51 a 55 anos e baixa densidade), inatividade física (82,9%), história pessoal de fratura nos últimos 5 anos (31,2% com baixa 
densidade) e observou-se o índice de massa corpórea - sobrepeso entre mulheres com densidade mineral óssea normal (44,7%) 
quando comparadas àquelas com baixa densidade (p<0,001). Conclusão: As mulheres na pósmenopausa apresentaram 
elevada prevalência de baixa densidade mineral óssea e fatores de risco associados. 
Descritores: Densidade Óssea; Envelhecimento; Promoção da Saúde.
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RESUMEN
Objetivo: Identificar la prevalencia de osteoporosis en mujeres en la postmenopausia y su asociación con factores de riesgo. 
Métodos: Estudio transversal realizado con 115 mujeres mayores en la postmenopausia que participaron del proyecto de 
extensión del Centro Universitario del Distrito Federal con duración de un año e inicio en 2017. Se ha mensurado la densidad 
mineral ósea por el Dual-energy X-ray absorptiometry en la columna lumbar (primera vértebra lumbar hasta la cuarta) y el cuello 
femoral. Se evaluaron los factores de riesgo para la densidad baja a través de entrevista. Se utilizó la prueba de chi-cuadrado de 
Pearson (p<0,05) para el análisis estadístico. Resultados: La media de edad encontrada ha sido de 67,8 ± 8,4 años y el tiempo 
de menopausia de 16,7 ± 6,2 años. La media de la densidad mineral ósea ha sido de -0,96 ± 1,42 para el cuello femoral y de 
-1,25 ± 1,75 para la columna lumbar (L1-L4). La prevalencia de densidad baja es del 66,9% para la columna lumbar y del 52,1% 
para el cuello femoral. Se encontró diferencia significativa para la edad (50,5% tenían entre 51 y 55 años y baja densidad), la 
inactividad física (82,9%), la historia personal de fractura en los últimos 5 años (31,2% con densidad baja) y se observó el índice 
de masa corporal – sobrepeso entre mujeres de densidad mineral ósea normal (44,7%) comparadas con aquellas de densidad 
baja (p<0,001). Conclusión: Las mujeres en la postmenopausia presentaron elevada prevalencia de densidad mineral ósea 
baja y los factores de riesgo asociados. 
Descriptores: Densidad Ósea; Envejecimiento; Promoción de la Salud.
INTRODUCTION 
Osteoporosis is a systemic bone disease characterized by loss of bone mass and deterioration of bone 
microarchitecture and bone quality leading to an increased risk of fragility fractures. Since there are no obvious 
symptoms of osteoporosis, this condition is often diagnosed after the occurrence of a fragility fracture. Thus, 
osteoporotic fractures highly burden the healthcare system in terms of increased hospitalizations, surgeries, and 
prolonged home care and rehabilitation requirements(1). For example, a large study conducted in the United States 
over a 12-year period (2000–2011) in postmenopausal women ≥55 years of age found that the hospitalization costs 
for osteoporotic fractures were greater than those for other serious conditions such as stroke, myocardial infarction 
and breast cancer(2). 
In the Latin America (LA) region, osteoporosis and osteoporotic fractures continue to be a major healthcare 
concern(1). The Latin American Vertebral Osteoporosis Study (LAVOS) conducted in five countries across LA with 
women ≥50 years old found that the standardized prevalence of radiographic vertebral fractures was 11.18 (95% 
confidence interval [CI] 9.23-13.4)(3). 
Chronic degenerative diseases appear with aging and there is delayed rehabilitation and signs of disease at 
advanced stages, which generally compromises older adults’ functionality and quality of life(4). Within this process, 
there is also a reduction in muscle mass and muscle strength, fatigue, alterations of gait and balance, loss of appetite 
and a consequent reduction in weight(5). 
According to the Brazilian Guidelines for the diagnosis and treatment of osteoporosis in postmenopausal women, 
the most important risk factors related to osteoporosis and postmenopausal fractures are: female gender, White or 
Asian ethnicity, family history, early menopause, reduced ovarian function before menopause (athlete’s amenorrhea, 
hyperprolactinemia, anorexia nervosa), poor diet (high caffeine intake, low calcium intake), poor life style (sedentary 
lifestyle, alcohol abuse, smoking) and fractures(4).
Menopause is a period in which women’s health status is significantly fluctuating. Its average onset is at the age 
of 50. The global average life expectancy for women is 74 years(6), so the time after menopause accounts for nearly 
one-third of women’s lives. The secretion of estrogen rapidly declines after menopause and leaves postmenopausal 
women (PMW) at a higher risk of various physical and mental illnesses compared with men(7).
Thus, osteoporosis ends up being a common disease in postmenopausal women due to age and hypoestrogenism, 
with an increased prevalence and incidence of fractures and hence a negative effect on the quality of life of such women(8). 
Every postmenopausal woman should be assessed for risk of fractures resulting from osteoporosis as women 
in this phase of life with a diagnosis of osteoporosis – but without having experienced fractures – may have a quality 
of life similar to postmenopausal women without osteoporosis(9). 
There is enough evidence to state that bone densitometry (BD) is currently the most effective method to estimate 
fracture risk in postmenopausal women(10). Preventative measures are especially important given that the available 
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treatments may conserve bone mass but cannot restore the osteoporotic bone to normality(11). Therefore, the objective 
of this study was to identify the prevalence of osteoporosis in postmenopausal women and its association with risk 
factors.
METHODS 
This quantitative cross-sectional study was conducted with 115 older women (out of 155) who participated in 
the extension project titled “Health Promotion and Healthy Aging” of the Federal District University Center (Centro 
Universitário do Distrito Federal - UDF) located in the Central region in western Brazil.
Inclusion criteria for the present study were: people aged 60 or over with or without hysterectomy who were 
part of the extension project and whose last menstrual period occurred at least 12 months prior to recruitment. 
Postmenopause was characterized as absence of the menstrual cycle for the last 12 months(4).  
Volunteers presenting other conditions or diseases associated with alterations in bone mass were excluded from 
the study: patients who had undergone oophorectomy, had a history of kidney disease, history of endocrinal disorders 
or diseases (hyperthyroidism, hypothyroidism, diabetes, Cushing Syndrome, Addison’s Disease), history of heart or 
lung diseases, Paget’s Disease, auto-immune diseases (Graves’ Disease or Hashimoto’s Disease), history of use 
of medication associated with alterations in bone metabolism (Hormone Replacement Therapy, corticoids, thyroid 
hormones, heparin, warfarin, phenobarbital, phenytoin, carbamazepine, lithium or methotrexate, supplementation 
with calcium or vitamin D). 
The older women were first approached during meetings of the Health Promotion and Healthy Aging project, which 
were carried out twice a week for 2 hours/day and included lectures on health promotion and disease prevention. 
During the meetings, the older women were informed about the objective of the study and invited to participate. Data 
were collected between September 2017 and February 2018 after signature of the Consent Form.
Data were collected through interviews in which the researcher applied a questionnaire with questions addressing 
the following variables: age, race, gynecological history (ages of menarche and menopause, time since menopause 
in years, presence of and time since hysterectomy in years), practice of physical activity, current smoking habits, 
osteoporosis and fractures (history of nontraumatic fractures in the last 5 years, 1st degree relative with osteoporosis). 
Women that did moderate aerobic exercise for at least 30 minutes five times a week (150 min/week) or did strength 
training three days a week were considered active(12). 
After completing the questionnaires, the older women were asked to come to the Physiology Laboratory of the 
Federal District University Center to carry out BD tests on the proximal femur and lumbar spine (L1-L4) using the 
Dual-energy X-ray absorptiometry technique (DEXA) and a Hologic QDR-2000 scanner. The criteria were computed 
in a single exam (the first exam performed) during the data collection period.  
The participants were classified according to the T-score and the criteria described in the Brazilian Guidelines 
for the diagnosis and treatment of osteoporosis in postmenopausal women(4): normal when ≥-1.0 SD, osteopenia 
when the value was between -1.0 and -2.4 SD, and osteoporosis when ≤-2.5 SD. The participants with total T-score 
values for spine and/or femoral neck <-1.0 SD (osteopenia and osteoporosis) were considered to have low bone 
mineral density (BMD). 
Weight measurement was taken using Filizola scales and height was measured using a stadiometer coupled to 
the scales. These anthropometric measurements were taken from all the participants – who wore light clothes and 
were barefoot during measurements – and were used to calculate Body Mass Index (BMI), which is the product of the 
division of body weight by the square of the height (W(Kg)/H(m)2). The data were classified according to the World 
Health Organization (WHO)(15) criteria, which classifies adult individuals with BMI < 18.5Kg/m2 as underweight, BMI 
between 18.5 and 24.9Kg/m2 as normal weight, BMI between 25 and 29.9 Kg/m2 as overweight, and BMI > 29.9Kg/
m2 as obese. 
The data were analyzed using the Stata software version 12.0 and underwent descriptive statistical analysis 
using measures of frequency and central tendency in addition to the Chi-squared test. The level of significance 
adopted was p<0.05. 
The project was approved by the Research Ethics Committee of the Federal District University Center (Centro 
Universitário do Distrito Federal - UDF) under Approval No. 1.931.184. 
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RESULTS 
The sample consisted of 115 older postmenopausal women who underwent bone densitometry. The mean age 
was 67.8 ± 8.4 years and the mean time since menopause was 16.7 ± 6.2 years. The mean BMD (in SD of T-score) 
was -0.96 ± 1.42 for the femoral neck and -1.25 ± 1.75 for the lumbar spine (L1-L4).
Table I shows the distribution of risk factors for osteoporosis. Most of the women in the sample were White 
(76.5%), sedentary (63.5%) and had normal BMI (50.4%). A few participants reported smoking (27.9%).
Table I - Distribution of risk factors for osteoporosis in older postmenopausal women. Brasília, Federal District, 
Brazil, 2018.
Risk factor n % p value*
Age (years)
     60 to 65 34 29.5 0.05
     66 to 70 57 49.6
     71 to 75 24 20.9
Race
     White 88 76.5 <0.001
     Mixed 19 16.5
     Black 8 7.0
Body mass index
     Underweight 11 9.6 <0.001
     Normal 58 50.4
     Overweight 36 31.3
     Obese 10 8.7
Age at Menopause (years)
     ≤ 45 12 10.4 <0.01
     46 a 50 45 39.1
     51 a 55 58 50.5
Physical activity  
    Yes 42 36.5 0.03
    No 73 63.5
Smoking
    Yes 32 27.9 0.02
    No 83 72.1
Nontraumatic fractures (last 5 years)
    Yes 18 15.6 <0.001
     No 97 84.4
1st degree relative with osteoporosis
    Yes 24 20.9 <0.001
    No 91 79.1
Hysterectomy
    Yes 28 24.3 <0.001
    No 87 75.7  
* Chi-squared Test
The prevalence rate of low BMD (osteopenia and/or osteoporosis) was 66.9% for the lumbar spine (L1-L4) and 
52.1% for the femoral neck (Table II). The classification of the data collected from the T-score was made considering 
the Brazilian Guidelines for the diagnosis and treatment of osteoporosis in postmenopausal women(4).
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Table II - Prevalence of low bone mineral density in older postmenopausal women. Brasília, Federal District, Brazil, 
2018.
DEXA                                                   Number of patients (%)   
Normal BMD Osteopenia Osteoporosis Low BMD*
Lumbar spine (L1-L4) 38 57 20 77 (66.9)
Femoral neck 55 50 10 60 (52.1)
*T-score < -1 SD (osteopenia + osteoporosis). DEXA: Dual-energy X-ray Absorptiometry; BMD: Bone Mineral Density
The clinical characteristics of the older postmenopausal women classified into normal or low BMD were subjected 
to statistical comparison and the data are shown in Table III. It There was an association of low BMD with age (p=0.04), 
White ethnicity (p=0.05), normal BMI (p<0.001), physical inactivity (p<0.001), smoking (p=0.03), nontraumatic fractures 
in the last five years (p<0.001), and having a first degree relative with osteoporosis (p=0.05).
Table III - Association between risk factors and the profile of bone mineral density of older postmenopausal women 
(n=115). Brasília, Distrito Federal, Brazil, 2018.
Low BMD Normal BMD p-value
Risk Factor n (%) n (%)  
Age (years)
    60 to 65 10 (15.1) 24 (48.9) 0.04*
    66 to 70 39 (59.1) 18 (36.7)
    71 to 75 17 (25.8) 7 (14.4)
Race  
    White 64 (82.1) 24 (64.9) 0.05*
    Mixed 11 (14.1) 8 (21.6)
    Black 3 (3.8) 5 (13.5)
Body mass index
    Underweight 7 (10.3) 4 (8.5) <0.001*
    Normal 42 (61.8) 16 (34.1)
    Overweight 15 (22.1) 21 (44.7)
    Obese 4 (5.8) 6 (12.7)
Age at menopause (years)
    ≤ 45 8 (10.9) 4 (9.5) 0.82
    46 to 50 28 (38.3) 17 (40.4)
    51 to 55 37 (50.8) 21 (50.1)
Physical activity  
    Yes 12 (17.1) 30 (66.7) <0.001*
    No 58 (82.9) 15 (33.3)
Smoking
    Yes 21 (24.7) 11 (36.7) 0.03*
    No 64 (75.3) 19 (63.3)
Nontraumatic fractures (last 5 years)
    Yes 10 (31.2) 8 (9.6) <0.001*
    No 22 (68.8) 75 (90.4)
1st degree relative with osteoporosis
    Yes 14 (40) 10 (12.5) 0.05*
    No 21 (60) 70 (87.5)
Hysterectomy
    Yes 16 (37.2) 12 (16.7) 0.06
    No 27 (62.8) 60 (83.3)  
* Chi-squared Test. BMD: Bone Mineral Density
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DISCUSSION  
Actions concerning the care for older adults taken by the healthcare team are necessary to outline the 
sociodemographic profile of this population group so as to promote health and prevent and treat diseases in this 
period of life and facilitate older adults’ access to public services that allow quality treatment and prevention(14).
In the present study, there was a high prevalence of osteopenia and osteoporosis among the older postmenopausal 
women. Densitometric diagnosis of osteopenia and/or osteoporosis in the lumbar spine and/or femoral neck was 
found in more than half of the women assessed. 
The prevalence of osteoporosis in postmenopausal women assessed in Indian studies ranged from 12% to 60% 
and it has been shown to increase with advancing age(15,16). Overall prevalence of osteoporosis in India is found to 
be higher than that reported in other countries, although studies have not been conducted in rural settings(17).
As demonstrated by these studies, the prevalence of osteoporosis in Brazil varies significantly according to the 
study methodology. Some studies based the diagnosis of osteoporosis on bone densitometry data and others relied 
on participants self-reporting. In 2010, researchers conducted a cross-sectional study that included 4,332 women 
aged > 40 years in São Paulo (São Paulo Osteoporosis Study [SAPOS]). The diagnosis of osteoporosis was made 
by DEXA and the prevalence rate of postmenopausal osteoporosis was 33%(18).
Women’s aging entails a decline in the functional capacity of various systems, including the bone system(5). 
Hormonal alterations in the menopause, especially estrogen deficiency, cause more bone resorption than bone 
formation, thereby leading to a reduction in bone mass and, consequently, osteoporosis(9). 
A study of 378 postmenopausal women found that 74% of them presented osteopenia and/or osteoporosis in the 
lumbar spine and/or femoral neck(19). A Brazilian study conducted in 2012 to evaluate the bone mass of 70 women 
aged 45-65 years found low BMD in the femoral neck (28.6%) and in the lumbar spine (45.7%)(20). 
Research shows that with advancing age there is a loss of balance between bone formation and resorption and 
that although age-related bone loss begins soon after peak bone mass it is more pronounced after the age of 65(21). 
The study conducted by the Women’s Health Initiative (WHI)(23) evaluated osteoporosis treatment and identified 
participant characteristics associated with treatment utilization after fracture or diagnosis of osteoporosis in the WHI. 
Of the 17,803 women who reported a new diagnosis of osteoporosis or fracture in the interval between enrollment 
and their final WHI visit, 3,457 reported both fracture and new diagnosis of osteoporosis, 7.926 reported only fracture 
and 6,420 reported only new diagnosis of osteoporosis(23).  
A study that assessed the prevalence of osteoporosis in Brazilian women over 50 years of age through bone 
density measurement found a prevalence rate of 40%(24). In the United States, a study of 600 patients assessed at 
the Wayne State University in Detroit found a prevalence rate of 52%(2).
Recently, a community-based study in Saudi Arabia revealed that 57% of the women presented low BMD (29.8% 
of them presented osteopenia and 27.2% presented osteoporosis)(25). Another study in South Korea reported a 32.3 
prevalence rate of osteoporosis and a 49.9% prevalence rate of osteopenia in the female population(26). A more 
recent study of postmenopausal women found that 42.5% of them were osteoporotic and 44.9% were osteopenic(27). 
Several cohort studies have been conducted to assess the family history of osteoporosis and osteoporotic 
fractures. Researchers have reported that the risk of hip and wrist fracture increased by 50% and 64%, respectively, 
in the presence of parental history of osteoporotic fracture of the hip or wrist. A family history seems to increase the 
risk of fracture independently of BMD(28). Other researchers found a negative correlation between a fracture history 
in a sister and 10-year fracture-free survival in perimenopausal women(29). A cohort study found osteopenia in 51% 
of the Caucasian women aged 60 to 89 years with a family history of osteoporosis(30).
Studies have shown the importance of ethnicity as a factor related to osteoporosis, thus indicating that Black 
women are at a lower risk of osteoporosis, unlike White and Asian women(31). Researchers have also demonstrated 
that the prevalence of osteoporosis and osteopenia is higher in White race or White skin individuals(32). In the present 
study, the individuals with White skin showed greater bone loss (osteopenia and osteoporosis).
There is evidence that exercise can prevent some of the complications associated with menopause, such as 
bone loss, loss of physical fitness and increased risk of osteoporosis(33). Physical exercise effectively decreases risk 
factors for falling and improves balance(33). 
Few cross-sectional studies have investigated associations between physical activity and osteoporosis. However, 
these studies focused on occupational physical activity and other lifestyle factors rather than recreational sports or 
physical activity(34). A study analyzed women aged ≥50 years and found that women whose work involved heavy 
physical labor had a lower prevalence of osteoporosis than women who had more sedentary jobs(35).
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Studies have reported that the areas most affected by osteoporosis are the femoral neck, lumbar spine, hip and 
trochanter and these areas also respond best to the results of the training program(33). Research with women with 
osteoporosis compared strength training, stretching and control group programs and showed the benefits of strength 
training interventions in improving posture and balance(36).
A study that analyzed the presence of hysterectomy found that women who had undergone hysterectomy presented 
artificial menopause despite the preservation of ovary functions. In the present study, there was no significant 
association between hysterectomy and osteoporosis(37).
Some limitations of the present study should be mentioned. First, the cross-sectional design of this study made 
it difficult to establish cause and effect relationships. Moreover, the study suffered losses that could lead to biases 
in the results.   
CONCLUSION  
A high prevalence of low bone mineral density was observed in the lumbar spine and femoral neck among older 
postmenopausal women. Knowledge of risk factors for low bone mass identified may assist professionals in identifying 
patients at risk of osteoporosis since evidence demonstrates that clinical history data, physical exams and specific 
complementary exams combined are key to preventing osteoporotic fractures.
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